Cita APA

Howe, J. A., Long, J., Black, S., Chase, R., McMonagle, P., Curry, S., . . . Howe, A. Y. M. (2014). Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants on the Efficacy of Boceprevir Combined With Peginterferon/Ribavirin. Open Forum Infect Dis.

Citación estilo Chicago

Howe, John A., Jianmin Long, Stuart Black, Robert Chase, Patricia McMonagle, Stephanie Curry, Seth Thompson, Mark J. DiNubile, y Anita Y. M. Howe. "Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants On the Efficacy of Boceprevir Combined With Peginterferon/Ribavirin." Open Forum Infect Dis 2014.

Cita MLA

Howe, John A., et al. "Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants On the Efficacy of Boceprevir Combined With Peginterferon/Ribavirin." Open Forum Infect Dis 2014.